High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.
Drug repurposing or repositioning is an important part of drug discovery that has been growing in the last few years for the development of therapeutic options in oncology. We applied this paradigm in a screening of a library of about 3,800 compounds (including FDA-approved drugs and pharmacological...
Main Authors: | Alessio Giubellino, Uma Shankavaram, Petra Bullova, Jan Schovanek, Yaqin Zhang, Min Shen, Nikita Patel, Abdel Elkahloun, Min-Jung Lee, Jane Trepel, Marc Ferrer, Karel Pacak |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3974653?pdf=render |
Similar Items
-
Pheochromocytoma (PHEO) and Paraganglioma (PGL)
by: Karel Pacak, et al.
Published: (2019-09-01) -
Targeting heat shock protein 90 for the treatment of malignant pheochromocytoma.
by: Alessio Giubellino, et al.
Published: (2013-01-01) -
Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
by: Stephanie M J Fliedner, et al.
Published: (2014-01-01) -
Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
by: Ying Pang, et al.
Published: (2019-03-01) -
New insights on the pathogenesis of paraganglioma and pheochromocytoma [version 1; referees: 2 approved]
by: Vitaly Kantorovich, et al.
Published: (2018-09-01)